Tokyo, Aug. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058482) titled 'A nationwide multi-institutional retrospective study to examine predictors of early postoperative recurrence in anatomically resectable pancreatic cancer treated with neoadjuvant chemotherapy (NAC-GS) (NAC-PIONEER trial)' on Aug. 1.
Study Type:
Observational
Primary Sponsor:
Institute - University of Toyama
Condition:
Condition - Resectable pancreatic cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To identify predictors of early recurrence within 6 months after surgery in patients with resectable pancreatic cancer who underwent NAC-GS.
Basic objectives2...